These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 8882050
1. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations. El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050 [Abstract] [Full Text] [Related]
2. Hyperprolactinemia in males with systemic lupus erythematosus. Mok CC, Lau CS, Lee KW, Wong RW. J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430 [Abstract] [Full Text] [Related]
3. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity. Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159 [Abstract] [Full Text] [Related]
4. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Leaños-Miranda A, Cárdenas-Mondragón G. Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247 [Abstract] [Full Text] [Related]
5. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR. J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507 [Abstract] [Full Text] [Related]
6. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622 [Abstract] [Full Text] [Related]
7. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460 [Abstract] [Full Text] [Related]
8. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116 [Abstract] [Full Text] [Related]
9. [Hyperprolactinemia in systemic lupus erythematosus. A prospective study of 38 cases]. Smiti Khanfir M, Ben Ghorbel I, Feki M, Lamloum M, Mebazaa A, Miled M, Houman MH. Tunis Med; 2004 Jun; 82(6):512-5. PubMed ID: 15517949 [Abstract] [Full Text] [Related]
10. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F. Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926 [Abstract] [Full Text] [Related]
11. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Heshmat NM, El-Kerdany TH. Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298 [Abstract] [Full Text] [Related]
12. Altered diurnal rhythm of prolactin in systemic sclerosis. Hilty C, Brühlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M. J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228 [Abstract] [Full Text] [Related]
13. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese. Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ. Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345 [Abstract] [Full Text] [Related]
14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA, El-Gendi HI, Ahmed HH. Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [Abstract] [Full Text] [Related]
15. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. Jara-Quezada L, Graef A, Lavalle C. J Rheumatol; 1991 Mar; 18(3):349-53. PubMed ID: 1856805 [Abstract] [Full Text] [Related]
16. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. Rovenský J, Juránková E, Rauová L, Blazícková S, Lukác J, Veselková Z, Jezová D, Vigas M. J Rheumatol; 1997 Dec; 24(12):2330-4. PubMed ID: 9415637 [Abstract] [Full Text] [Related]
17. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide. Hrycek A, Pochopień-Kenig G, Scieszka J. Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721 [Abstract] [Full Text] [Related]
18. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E. J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664 [Abstract] [Full Text] [Related]
20. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus. Yoshio T, Masuyama JI, Minota S, Kaneko N, Iwamoto M, Okazaki H, Mimori A, Takeda A, Kano S. J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]